These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 22538135)

  • 41. Novel insulins: expanding options in diabetes management.
    Gerich JE
    Am J Med; 2002 Sep; 113(4):308-16. PubMed ID: 12361817
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Insulin analogs: impact on treatment success, satisfaction, quality of life, and adherence.
    Hartman I
    Clin Med Res; 2008 Sep; 6(2):54-67. PubMed ID: 18801953
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Insulin glulisine: an evaluation of its pharmacodynamic properties and clinical application.
    Helms KL; Kelley KW
    Ann Pharmacother; 2009 Apr; 43(4):658-68. PubMed ID: 19336657
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nasal absorption of mixtures of fast-acting and long-acting insulins.
    Pillion DJ; Fyrberg MD; Meezan E
    Int J Pharm; 2010 Mar; 388(1-2):202-8. PubMed ID: 20080164
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of Sizes of Aggregates of Insulin Analogs and the Conformations of the Constituent Protein Molecules: A Concomitant Dynamic Light Scattering and Raman Spectroscopy Study.
    Zhou C; Qi W; Lewis EN; Carpenter JF
    J Pharm Sci; 2016 Feb; 105(2):551-558. PubMed ID: 26869418
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adsorption of insulin with varying self-association profiles to a solid Teflon surface--influence on protein structure, fibrillation tendency and thermal stability.
    Jorgensen L; Bennedsen P; Hoffmann SV; Krogh RL; Pinholt C; Groenning M; Hostrup S; Bukrinsky JT
    Eur J Pharm Sci; 2011 Apr; 42(5):509-16. PubMed ID: 21352910
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Photoacoustic imaging reveals mechanisms of rapid-acting insulin formulations dynamics at the injection site.
    Khadria A; Paavola CD; Maslov K; Valenzuela FA; Sperry AE; Cox AL; Cao R; Shi J; Brown-Augsburger PL; Lozano E; Blankenship RL; Majumdar R; Bradley SA; Beals JM; Oladipupo SS; Wang LV
    Mol Metab; 2022 Aug; 62():101522. PubMed ID: 35671972
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison.
    Ilag LL; Kerr L; Malone JK; Tan MH
    Clin Ther; 2007 Jun; 29(6 Pt 1):1254-70. PubMed ID: 18036388
    [TBL] [Abstract][Full Text] [Related]  

  • 49. BioChaperone Lispro versus faster aspart and insulin aspart in patients with type 1 diabetes using continuous subcutaneous insulin infusion: A randomized euglycemic clamp study.
    Heise T; Meiffren G; Alluis B; Seroussi C; Ranson A; Arrubla J; Correia J; Gaudier M; Soula O; Soula R; DeVries JH; Klein O; Bode B
    Diabetes Obes Metab; 2019 Apr; 21(4):1066-1070. PubMed ID: 30565407
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Insulin lispro: its role in the treatment of diabetes mellitus.
    Campbell RK; Campbell LK; White JR
    Ann Pharmacother; 1996 Nov; 30(11):1263-71. PubMed ID: 8913409
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of a novel excipient poly(ethylene glycol)-b-poly(L-histidine) in retention of physical stability of insulin at aqueous/organic interface.
    Taluja A; Bae YH
    Mol Pharm; 2007; 4(4):561-70. PubMed ID: 17439239
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of physicochemical variables of regular insulin formulations on their absorption from the subcutaneous tissue.
    Polaschegg E
    Diabetes Res Clin Pract; 1998 Apr; 40(1):39-44. PubMed ID: 9699089
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A randomized trial comparing continuous subcutaneous insulin infusion of insulin aspart versus insulin lispro in children and adolescents with type 1 diabetes.
    Weinzimer SA; Ternand C; Howard C; Chang CT; Becker DJ; Laffel LM;
    Diabetes Care; 2008 Feb; 31(2):210-5. PubMed ID: 17989308
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Insulin aspart: a new rapid-acting insulin analog.
    Setter SM; Corbett CF; Campbell RK; White JR
    Ann Pharmacother; 2000 Dec; 34(12):1423-31. PubMed ID: 11144701
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of recombinant human insulin and biosynthetic insulin analogues by multiplexed targeted unlabeled mass spectrometry of proteotypic tryptic peptides.
    Qasem RJ; Aldawsari AS; Almutairi FE; Alsadoon AS
    J Pharm Biomed Anal; 2019 Aug; 172():357-363. PubMed ID: 31096094
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of ethylenediamine on chemical degradation of insulin aspart in pharmaceutical solutions.
    Poulsen C; Jacobsen D; Palm L
    Pharm Res; 2008 Nov; 25(11):2534-44. PubMed ID: 18607693
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Insulin aspart: a review of its use in the management of type 1 and 2 diabetes mellitus.
    Chapman TM; Noble S; Goa KL
    Drugs; 2002; 62(13):1945-81. PubMed ID: 12215068
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Multicenter Randomized Trial Evaluating Fast-Acting Insulin Aspart in the Bionic Pancreas in Adults with Type 1 Diabetes.
    Beck RW; Russell SJ; Damiano ER; El-Khatib FH; Ruedy KJ; Balliro C; Li Z; Calhoun P
    Diabetes Technol Ther; 2022 Oct; 24(10):681-696. PubMed ID: 36173235
    [No Abstract]   [Full Text] [Related]  

  • 59. 4S-fluorination of ProB29 in insulin lispro slows fibril formation.
    Breunig SL; Chapman AM; LeBon J; Quijano JC; Ranasinghe M; Rawson J; Demeler B; Ku HT; Tirrell DA
    J Biol Chem; 2024 Jun; 300(6):107332. PubMed ID: 38703998
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Safety of insulin analogs during pregnancy: a meta-analysis.
    Lv S; Wang J; Xu Y
    Arch Gynecol Obstet; 2015 Oct; 292(4):749-56. PubMed ID: 25855052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.